CN1161654A - 去除毛发的方法 - Google Patents
去除毛发的方法 Download PDFInfo
- Publication number
- CN1161654A CN1161654A CN95195847A CN95195847A CN1161654A CN 1161654 A CN1161654 A CN 1161654A CN 95195847 A CN95195847 A CN 95195847A CN 95195847 A CN95195847 A CN 95195847A CN 1161654 A CN1161654 A CN 1161654A
- Authority
- CN
- China
- Prior art keywords
- hair
- hair follicle
- photosensitizer
- skin
- follicle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 35
- 210000004209 hair Anatomy 0.000 title claims abstract description 25
- 150000001875 compounds Chemical class 0.000 claims abstract description 18
- 210000003780 hair follicle Anatomy 0.000 claims description 67
- 239000003504 photosensitizing agent Substances 0.000 claims description 32
- 210000003491 skin Anatomy 0.000 claims description 28
- 239000003053 toxin Substances 0.000 claims description 11
- 231100000765 toxin Toxicity 0.000 claims description 11
- 239000011248 coating agent Substances 0.000 claims description 8
- 238000000576 coating method Methods 0.000 claims description 8
- 239000002243 precursor Substances 0.000 claims description 8
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 claims description 6
- 229960000907 methylthioninium chloride Drugs 0.000 claims description 6
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 claims description 6
- 230000002951 depilatory effect Effects 0.000 claims description 5
- 230000003660 hair regeneration Effects 0.000 claims description 5
- 150000004032 porphyrins Chemical class 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical group NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 claims description 4
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 4
- 229960002749 aminolevulinic acid Drugs 0.000 claims description 4
- SURLGNKAQXKNSP-DBLYXWCISA-N chlorin Chemical class C\1=C/2\N/C(=C\C3=N/C(=C\C=4NC(/C=C\5/C=CC/1=N/5)=CC=4)/C=C3)/CC\2 SURLGNKAQXKNSP-DBLYXWCISA-N 0.000 claims description 4
- 241001597008 Nomeidae Species 0.000 claims description 3
- 230000003213 activating effect Effects 0.000 claims description 3
- 241000124008 Mammalia Species 0.000 claims description 2
- 238000010297 mechanical methods and process Methods 0.000 claims description 2
- 238000005987 sulfurization reaction Methods 0.000 claims description 2
- 230000005764 inhibitory process Effects 0.000 abstract description 8
- 230000003779 hair growth Effects 0.000 abstract description 6
- 230000007774 longterm Effects 0.000 abstract description 4
- 230000009849 deactivation Effects 0.000 description 23
- 230000035617 depilation Effects 0.000 description 20
- KSFOVUSSGSKXFI-GAQDCDSVSA-N CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O Chemical compound CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O KSFOVUSSGSKXFI-GAQDCDSVSA-N 0.000 description 10
- 229950003776 protoporphyrin Drugs 0.000 description 10
- 230000002779 inactivation Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 4
- 238000002665 ion therapy Methods 0.000 description 4
- 210000004918 root sheath Anatomy 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 230000000340 anti-metabolite Effects 0.000 description 3
- 229940100197 antimetabolite Drugs 0.000 description 3
- 239000002256 antimetabolite Substances 0.000 description 3
- 239000007844 bleaching agent Substances 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 230000004907 flux Effects 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 210000001732 sebaceous gland Anatomy 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- MHIITNFQDPFSES-UHFFFAOYSA-N 25,26,27,28-tetrazahexacyclo[16.6.1.13,6.18,11.113,16.019,24]octacosa-1(25),2,4,6,8(27),9,11,13,15,17,19,21,23-tridecaene Chemical class N1C(C=C2C3=CC=CC=C3C(C=C3NC(=C4)C=C3)=N2)=CC=C1C=C1C=CC4=N1 MHIITNFQDPFSES-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000000589 cicatrix Anatomy 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003746 feather Anatomy 0.000 description 2
- 239000000834 fixative Substances 0.000 description 2
- 210000000442 hair follicle cell Anatomy 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000002445 nipple Anatomy 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 229920005479 Lucite® Polymers 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 239000008151 electrolyte solution Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 210000004919 hair shaft Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000000937 inactivator Effects 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- XJCPMUIIBDVFDM-UHFFFAOYSA-M nile blue A Chemical compound [Cl-].C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4[O+]=C3C=C(N)C2=C1 XJCPMUIIBDVFDM-UHFFFAOYSA-M 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 229940109328 photofrin Drugs 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 230000001550 time effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q9/00—Preparations for removing hair or for aiding hair removal
- A61Q9/04—Depilatories
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/203—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser applying laser energy to the outside of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00452—Skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00452—Skin
- A61B2018/00476—Hair follicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/42—Colour properties
- A61K2800/43—Pigments; Dyes
- A61K2800/434—Luminescent, Fluorescent; Optical brighteners; Photosensitizers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/58—Metal complex; Coordination compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/062—Photodynamic therapy, i.e. excitation of an agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Optics & Photonics (AREA)
- Surgery (AREA)
- Radiology & Medical Imaging (AREA)
- Otolaryngology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Electromagnetism (AREA)
- Medical Informatics (AREA)
- Pathology (AREA)
- Cosmetics (AREA)
- Apparatuses For Bulk Treatment Of Fruits And Vegetables And Apparatuses For Preparing Feeds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明的特征在于一种去除毛发的方法,它包括经机械法或化学法去除毛发,露出毛发的毛囊,然后处理毛囊,抑制其毛发再生能力。去除毛发有利于毛囊对灭活毛囊化合物的吸收,从而能长期抑制毛发生长。
Description
发明背景
本发明涉及从皮肤上去除毛发。目前用于除毛的方法包括剃除、涂敷脱毛蜡、电蚀、机械脱毛、化学法脱毛、采用激光(见例如美国专利3538919和4388924),以及采用吸光物质(见例如美国专利5226907)。其中某些方法在施用时疼痛或无效,或者费时,而其它方法缺乏长期效果。
发明简述
本发明人发现在机械脱毛后,经局部给药使毛囊失活可长期抑制毛发生长。
因此,本发明的特征在于一种去除哺乳动物皮肤上毛发的方法,它包括经机械法或化学法脱毛露出毛囊,然后处理毛囊,从而抑制其毛发再生能力。
脱毛后形成直通毛囊的通道,从而可以大大增强毛囊吸收药剂的能力,该药剂可使毛囊促进毛发生长的性能失活。因此,本发明提供了一种去除毛发并可长期抑制毛发生长的有效方法。
在优选实施方案中,所采用的脱毛方法包括冷敷、热敷,以及采用机械装置从毛囊中拔除毛发。
脱毛后,可通过许多方法使毛囊促进毛发生长的性能失活,它们包括:使用光敏剂,然后暴露于光线下,再使用柔和毒素并通入电流。光灭活一般包括(1)在皮肤上涂敷光敏剂,(2)毛囊吸收光敏剂,和(3)光敏剂的活化,从而使毛囊促进毛发生长的性能失活,抑制毛发生长。光敏剂优选是低毒性的,但应在特定的光波长下可活化。优选光波长可深达毛囊;适用的波长一般为550-800nm。优选的光敏剂包括卟啉、酞菁、二氢卟酚,以及红紫素,但不仅限于此。适用的光敏剂的实例包括氨基-γ-酮戊酸(ALA;在630nm下活化)亚甲基蓝(在660nm下活化)尼罗蓝-A衍生物、卟啉衍生物如苯并卟啉衍生物(BPD;在690nm下活化),叶菲尔钠(例如PHOTOFRINTM卟菲尔钠;630nm下活化),卟啉,二氢卟酚,以及酞菁。光敏剂可通过光化学或光热机理进行作用。光热敏剂包括靛菁绿(在690-800nm下活化)以及其它染料。
也可采用柔和的毒素对毛囊灭活。在该具体实施方案中,脱毛后涂敷毒素,从而使毒素进入毛囊。该毒素经足够长的时间作用于毛囊使毛囊失活而不应对周围皮肤造成实质损伤(例如,溃疡和形成疤痕);一般0.1-5分钟的时间足够长。适用的毒素包括漂白剂(例如次氯酸盐和过氧化物),抗代谢药(例如,5-氟尿嘧啶),溶剂(例如,丙酮、醇、酚,和醚),碘释放剂,洗涤剂和表面活性剂,以及醛和其它交联蛋白固定剂(例如,戊二醛、甲醛、和乙醛),但不仅限于此。
另外,本发明中可采用多种毒素,可先后或同时涂敷(例如,可将表面活性剂、溶剂、和抗代谢药共同使用或先后使用)。皮肤学领域的技术人员可根据本发明的指导确定毒素吸收所需的适宜条件。
本发明的方法中也可采用离子电渗技术使毛囊灭活化合物进入毛囊。在该具体实施方案中,脱毛后,在皮肤上涂敷含有离子毛囊灭活化合物的溶液,然后对皮肤通电。电流可增进毛囊灭活化合物进入皮肤的能力。适用的溶液包括:次氯化物漂白剂、氯盐溶液、离子洗涤剂,和离子光敏剂或其前体(例如,ALA和亚甲基蓝),但并不仅限于此。加电流的合适方法和装置是本领域已知的(例如见Iomed Inc.,Salt Lake City,UT的使用说明)。在本发明的实施方案中也可通过离子电渗施用麻醉剂(例如利多卡因)以减轻疼痛。也可采用其它多种方法包括超声波或压力波法、加热法、表面活性剂法,以及毛细作用来使毛囊灭活物质进入毛囊。
“脱毛”是指从毛囊中去除毛发。可采用化学或机械方法进行脱毛,如冷敷、热敷或拔除毛发从而使毛囊显露出来。
“毛囊”是指容纳和生长毛发的表皮向下生长物和泡状膨胀组织。毛囊的各部分包括毛根外鞘、毛根内鞘、结缔组织乳头、毛母细胞、多能细胞(约位于皮肤表面以下大约1mM处)、以及皮脂腺。
毛囊的“灭活”是指对毛囊毛发再生能力的抑制和/或对脸部、体表或身体其它易于发生痤疮的部位的皮脂腺的抑制。可通过破坏毛囊的一个或多个部分来抑制毛发生长。根据毛囊灭活所使用的具体成分来确定要破坏的确切部分。可破坏的部分包括:毛根外鞘、毛根内鞘、结缔组织乳头、毛母细胞、皮脂腺,以及多能细胞(约位于皮肤表面以下大约1mM处)。
“光敏剂”是指一种化合物,当它曝露于某一特定通量下时可以对毛囊灭活,或者也指这种化合物的前体,它(例如,ALA)可以在活细胞中转化成光敏剂
光敏剂或光敏剂前体的“活化”是指将光敏剂或前体曝露在脉冲或连续方式的光线下,使毛囊灭活。
用在此处的缩写为:ALA:氨基-γ-酮戊酸BPD:苯并卟啉衍生物PRIX:原卟啉IX
通过以下优选具体实施方案的描述和权利要求书,本发明的其它特点和优点将是明显的。发明详述
首先描述附图。附图
图中是局部脱毛并涂敷20%ALA的人体皮肤上PRIX的荧光图。脱毛后毛囊的选择性吸收
脱毛后使显露出的毛囊对毛囊灭活化合物产生选择性吸收。
以下的方法是通过冷敷法使人体部分皮肤脱毛。冷敷法的实施是通过涂敷粘稠的液状脱毛蜡或树脂混合物(例如,MYEPILTM蜡),再迅速揭起,将每根毛发从其毛囊中拔出来。剃除但不是脱去皮肤上其它部位的毛发以作对比,然后如下处理皮肤所有部位。在皮肤上涂敷20%(重量)光敏剂ALA的乙醇/水溶液,并用塑料覆盖物覆盖在经处理的皮肤上2-4小时。ALA是原卟啉IX(PRIX)的前体,它可以在活细胞中转化为PRIX。2-4小时的时间足够使ALA被脱毛后的毛囊吸收(吸收在几分钟就已发生),也足够使ALA转化为PRIX。皮肤吸收ALA,转化为PRIX,然后拍荧光照片(420nm激发;600+nm发射)。图中央显示出较强的荧光,表示脱毛后的毛囊细胞可将ALA转化为PRIX。该图也表明,与未脱毛的毛囊相比,脱毛可以使光化学物质选择性地进入经脱毛的毛囊(位于图中央)。因此,脱毛有利于灭活剂进入毛囊。对毛发生长的抑制
脱毛或剃除毛发(作为对比)并涂敷ALA后,将皮肤曝露于630nm(氩染料激光)、通量在0-300J/cm2内变化的光中,使毛囊灭活。处理后3-6个月,毛发再生数为0%至约50%。相反,未经脱毛而采用剃除毛发的,毛发再生为100%。这些数据也表明:该方法的效能随着通量的提高而提高。其它实施方案
其它实施方案也属于以下权利要求的范围。例如,可以采用机械装置而不是涂敷脱毛蜡来从毛囊中去除毛发。也可采用化学品,例如,化学脱毛霜来破坏毛干中的二硫键。
ALA以外的光敏剂也可用于毛囊灭活;它们的实例包括卟啉、酞菁、二氢卟酚、红紫素、以及若丹明或尼罗蓝的衍生物,但并不仅限于此。实际上我发现了局部涂敷亚甲基蓝后,经离子电渗法并经660nm光照可促进其被吸收,证明毛囊受到了破坏。我还检测到涂敷硫化酞菁氯化铝。并经760nm光照后毛囊的破坏。因此,可用于本发明的光敏剂并不仅限于ALA。适宜的光敏剂浓度一般为0.1-20%;更优选浓度约为0.5-5%;最优选浓度约为1%。这里提出了某些适用的光敏剂的实例和适宜的波长;其它实例对于光化学领域的技术人员来说也将是显而易见的。
也可采用柔和的毒素如漂白剂、抗代谢药、溶剂、碘释放剂、洗涤剂、表面活性剂,以及交联蛋白固定剂,其使用浓度应可使毛囊灭活但不会对周围的皮肤造成实质损伤(例如,疤痕或造成溃疡)。适宜的浓度一般为1-20%,毛囊对其吸收一般为0.1-5分钟。
可采用各种可用于皮肤的赋形剂(例如,醇溶液和水溶液,水包油或油包水型膏霜、乳剂或油膏剂)周来附载该毛囊灭活化合物,适用的赋形剂形式包括乳液、膏霜和液体,但并不仅限于此。所采用的载体可以使光敏剂或毒素进入毛囊,当载体和皮肤间存在较低的表面张力从而可促进毛细管作用时,吸收效果最好。除简单的毛细作用外,还可采用其它方法使灭活毛囊成分进入毛囊,如超声波法、加热法、压力波法、离子电渗法或表面活性剂法。根据所采用的方法、灭活毛囊化合物的特性、以及所采用的赋形剂等因素来确定吸收灭活毛囊组分所需的时间。一般1-5分钟的时间足够用于吸收灭活毛囊化合物。
也可采用离子电渗法使毛囊易于吸收该灭活毛囊的化合物。皮肤角质层起电阻屏障作用。脱毛后,空毛囊成为外部的电解质溶液进入皮肤内部的主要通路。因此,离子电渗法可以增进离子性灭活毛囊化合物的吸收。在该实施方案中在皮肤上涂敷灭活毛囊化合物,然后施用使该化合物进行离子电渗的同极电极。(见Iomde Inc.,Salt Lake City,UT提供的离子电渗装置的使用说明)。离子性毛囊灭活化合物的实例有:ALA、亚甲基蓝、次氯酸盐漂白剂、氯化物溶液、以及离子表面活性剂。
光敏剂前体(例如,ALA)转化成光敏剂(例如,PRIX)一般在2-4小时内。通过上述的荧光拍摄可容易地测定毛囊吸收光敏剂前体的能力及其在毛囊细胞内转化为光敏剂的能力。在用光对该光敏剂进行活化时,由于对皮肤照射渐强光,可以在皮肤表面涂敷一层矿物油,并覆盖人造荧光树脂片或其它与皮肤折射率相近的透明材料。通过对局部皮肤试用该方法并测定其后毛发的生长情况可以容易地测定出去除毛发以及使毛囊失活所需的最佳条件。
Claims (10)
1.一种去除哺乳动物皮肤上毛发的方法,该方法包括a)经机械法或化学法去除毛,从而露出毛发的毛囊,然后b)处理所述毛囊以抑制其毛发再生能力。
2.权利要求1的方法,其中步骤a)是通过涂敷脱毛蜡来完成的。
3.权利要求1的方法,其中步骤b)包括向所述毛囊施用光敏剂,然后使所述化合物活化。
4.权利要求3的方法,其中所述的光敏剂选自氨基-γ-酮戊酸、亚甲基蓝、尼罗蓝-A衍生物、酞菁、卟啉衍生物、二氢卟酚、以及红紫素。
5.权利要求4的方法,其中所述的光敏剂是氨基-γ-酮戊酸。
6.权利要求4的方法,其中所述的光敏剂是亚甲基蓝。
7.权利要求4的方法,其中所述的光敏剂是硫化酞菁氯化铝。
8.权利要求1的方法,其中步骤b)包括在皮肤上通入电流。
9.权利要求1的方法,其中步骤b)包括对毛囊施用柔和毒素。
10.权利要求3的方法,其中所述的光敏剂是一种前体化合物,它可以在活细胞中转化为光敏剂。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/314,082 | 1994-09-28 | ||
US08/314,082 US5669916A (en) | 1994-09-28 | 1994-09-28 | Method of hair removal |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1161654A true CN1161654A (zh) | 1997-10-08 |
CN1179766C CN1179766C (zh) | 2004-12-15 |
Family
ID=23218481
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB95195847XA Expired - Fee Related CN1179766C (zh) | 1994-09-28 | 1995-09-22 | 去除毛发的方法 |
Country Status (10)
Country | Link |
---|---|
US (2) | US5669916A (zh) |
EP (1) | EP0783347B1 (zh) |
JP (1) | JPH10506554A (zh) |
KR (1) | KR970706038A (zh) |
CN (1) | CN1179766C (zh) |
AT (1) | ATE273049T1 (zh) |
CA (1) | CA2201123C (zh) |
DE (1) | DE69533360T2 (zh) |
ES (1) | ES2225848T3 (zh) |
WO (1) | WO1996009853A1 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113730576A (zh) * | 2021-08-31 | 2021-12-03 | 佛山市第一人民医院(中山大学附属佛山医院) | 一种激光脱毛的纳米光热材料及其制备方法 |
CN114246673A (zh) * | 2021-12-21 | 2022-03-29 | 西安欧益光电科技有限公司 | 一种超声辅助激光高效精准脱毛美容方法及装置 |
Families Citing this family (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE175562T1 (de) * | 1994-08-02 | 1999-01-15 | Gabriel Bernaz | Flexible elektrode zur behandlung der haut mit hochfrequenz |
US5669916A (en) * | 1994-09-28 | 1997-09-23 | The General Hospital Corporation | Method of hair removal |
US6143287A (en) * | 1996-02-27 | 2000-11-07 | New York Blood Center, Inc. | Method and composition for hair removal |
US6094594A (en) * | 1996-08-14 | 2000-07-25 | Tapper; Robert | Hair removal system |
US20060095097A1 (en) * | 1996-10-30 | 2006-05-04 | Provectus Devicetech, Inc. | Treatment of pigmented tissue using optical energy |
US7036516B1 (en) | 1996-10-30 | 2006-05-02 | Xantech Pharmaceuticals, Inc. | Treatment of pigmented tissues using optical energy |
CA2206203A1 (en) | 1997-05-27 | 1998-11-27 | University Of British Columbia | Photoactivation of endogenous porphyrins for treatment of psoriasis |
US6104959A (en) | 1997-07-31 | 2000-08-15 | Microwave Medical Corp. | Method and apparatus for treating subcutaneous histological features |
US6090101A (en) * | 1997-12-10 | 2000-07-18 | Quon; David K. | Method and apparatus for permanent hair removal |
US6080146A (en) * | 1998-02-24 | 2000-06-27 | Altshuler; Gregory | Method and apparatus for hair removal |
US6030374A (en) * | 1998-05-29 | 2000-02-29 | Mcdaniel; David H. | Ultrasound enhancement of percutaneous drug absorption |
US6398753B2 (en) | 1998-04-03 | 2002-06-04 | Mcdaniel David H. | Ultrasound enhancement of percutaneous drug absorption |
US7004933B2 (en) * | 1998-05-29 | 2006-02-28 | Light Bioscience L.L.C. | Ultrasound enhancement of percutaneous drug absorption |
US20060212025A1 (en) | 1998-11-30 | 2006-09-21 | Light Bioscience, Llc | Method and apparatus for acne treatment |
US6887260B1 (en) * | 1998-11-30 | 2005-05-03 | Light Bioscience, Llc | Method and apparatus for acne treatment |
US6283956B1 (en) | 1998-11-30 | 2001-09-04 | David H. McDaniels | Reduction, elimination, or stimulation of hair growth |
US9192780B2 (en) | 1998-11-30 | 2015-11-24 | L'oreal | Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders |
US6936044B2 (en) | 1998-11-30 | 2005-08-30 | Light Bioscience, Llc | Method and apparatus for the stimulation of hair growth |
US6183773B1 (en) * | 1999-01-04 | 2001-02-06 | The General Hospital Corporation | Targeting of sebaceous follicles as a treatment of sebaceous gland disorders |
EP1187659A1 (en) | 1999-04-27 | 2002-03-20 | The General Hospital Corporation doing business as Massachusetts General Hospital | Phototherapy method for treatment of acne |
AUPQ044499A0 (en) * | 1999-05-19 | 1999-06-10 | Commonwealth Scientific And Industrial Research Organisation | Control of wool growth |
AU777772B2 (en) * | 1999-05-19 | 2004-10-28 | Commonwealth Scientific And Industrial Research Organisation | Control of wool growth in sheep and related animals |
GB9912998D0 (en) | 1999-06-04 | 1999-08-04 | Sls Biophile Limited | Depilation |
US6358242B1 (en) * | 1999-11-12 | 2002-03-19 | Ceramoptec Industries, Inc. | Post laser treatment for permanent hair removal |
US6436094B1 (en) | 2000-03-16 | 2002-08-20 | Laserscope, Inc. | Electromagnetic and laser treatment and cooling device |
ATE463237T1 (de) * | 2000-08-16 | 2010-04-15 | Gen Hospital Corp | Topische aminolevulinsäure-photodynamische therapie für akne vulgaris |
DE10060467B4 (de) * | 2000-12-05 | 2007-02-22 | Wella Ag | Pulverförmiges Blondiermittel oder Haarfärbemittel und Verfahren zu dessen Herstellung |
GB2370229A (en) * | 2000-12-22 | 2002-06-26 | Icn Photonics Ltd | Light delivery system for improving the appearance of skin |
US6685927B2 (en) * | 2001-09-27 | 2004-02-03 | Ceramoptec Industries, Inc. | Topical application of chromophores for hair removal |
US7264629B2 (en) * | 2001-11-09 | 2007-09-04 | Qlt, Inc. | Photodynamic therapy for the treatment of hair loss |
JP2005514346A (ja) * | 2001-11-09 | 2005-05-19 | キュー エル ティー インク. | 光感作剤及び皮膚浸透エンハンサーを含有する組成物並びに光力学療法におけるそれらの使用 |
EP1312353A1 (en) * | 2001-11-16 | 2003-05-21 | Ecole Polytechnique Federale De Lausanne (Epfl) | Method for hair removal |
US20040082940A1 (en) * | 2002-10-22 | 2004-04-29 | Michael Black | Dermatological apparatus and method |
AUPR988202A0 (en) | 2002-01-09 | 2002-01-31 | University Of Adelaide, The | Animal husbandry hair removal method |
WO2004000098A2 (en) | 2002-06-19 | 2003-12-31 | Palomar Medical Technologies, Inc. | Method and apparatus for treatment of cutaneous and subcutaneous conditions |
US7703458B2 (en) * | 2003-02-21 | 2010-04-27 | Cutera, Inc. | Methods and devices for non-ablative laser treatment of dermatologic conditions |
US7413567B2 (en) | 2003-02-25 | 2008-08-19 | Spectragenics, Inc. | Optical sensor and method for identifying the presence of skin |
WO2004075718A2 (en) | 2003-02-25 | 2004-09-10 | Spectragenics, Inc. | Eye-safe dermatologic treatment apparatus and method |
US7981111B2 (en) | 2003-02-25 | 2011-07-19 | Tria Beauty, Inc. | Method and apparatus for the treatment of benign pigmented lesions |
US8709003B2 (en) | 2003-02-25 | 2014-04-29 | Tria Beauty, Inc. | Capacitive sensing method and device for detecting skin |
US7118563B2 (en) | 2003-02-25 | 2006-10-10 | Spectragenics, Inc. | Self-contained, diode-laser-based dermatologic treatment apparatus |
EP2604216B1 (en) | 2003-02-25 | 2018-08-22 | Tria Beauty, Inc. | Self-contained, diode-laser-based dermatologic treatment apparatus |
JP4361083B2 (ja) | 2003-02-25 | 2009-11-11 | トリア ビューティ インコーポレイテッド | 目に安全な内蔵型毛再生抑制装置 |
WO2004092335A2 (en) | 2003-04-10 | 2004-10-28 | Light Bioscience, Inc. | Photomodulation methods and devices for regulating cell proliferation and gene expression |
EP1617909A1 (en) * | 2003-04-23 | 2006-01-25 | QLT Inc. | Hair growth |
US7101362B2 (en) * | 2003-07-02 | 2006-09-05 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Steerable and shapable catheter employing fluid force |
JP4739202B2 (ja) * | 2003-07-31 | 2011-08-03 | ジェントルウェイブス エルエルシー | 熱傷、創傷、および関連皮膚疾患の光力学治療のためのシステムおよび方法 |
MXPA06003466A (es) * | 2003-10-14 | 2006-06-05 | Gregg S Homer | Metodo y dispositivo para la retraccion dermica y la generacion de colageno y elastina. |
WO2005038762A1 (en) * | 2003-10-17 | 2005-04-28 | Scanvue Technologies Llc | Differentiating circuit display |
US8777935B2 (en) * | 2004-02-25 | 2014-07-15 | Tria Beauty, Inc. | Optical sensor and method for identifying the presence of skin |
EP2343021A1 (en) | 2004-04-01 | 2011-07-13 | The General Hospital Corporation | Method and apparatus for dermatological treatment and tissue reshaping |
US20050220734A1 (en) * | 2004-04-02 | 2005-10-06 | Allergan, Inc. | Therapy for melanin related afflictions |
GB2413074A (en) * | 2004-04-13 | 2005-10-19 | Reckitt Benckiser | Depilatory method |
US7241291B2 (en) * | 2004-06-02 | 2007-07-10 | Syneron Medical Ltd. | Method and system for skin treatment using light energy and skin deformation |
US7837675B2 (en) | 2004-07-22 | 2010-11-23 | Shaser, Inc. | Method and device for skin treatment with replaceable photosensitive window |
US20060034952A1 (en) * | 2004-08-13 | 2006-02-16 | Kondhalkar Mrinmayee B | Agent for inhibiting the growth of mammalian hair |
BRPI0610603A2 (pt) | 2005-04-22 | 2010-07-06 | Ecpoint Medical Inc | aparelho para fornecer tratamento eletrolìtico ao tecido, método para o tratamento de uma porção in vivo de tecido, método para melhorar cosmeticamente uma área de pele não estética usando um tratamento eletrolìtico e método de depilação |
US7856985B2 (en) | 2005-04-22 | 2010-12-28 | Cynosure, Inc. | Method of treatment body tissue using a non-uniform laser beam |
US20070078290A1 (en) * | 2005-09-30 | 2007-04-05 | Esenaliev Rinat O | Ultrasound-based treatment methods for therapeutic treatment of skin and subcutaneous tissues |
FR2892012B1 (fr) * | 2005-10-17 | 2008-07-18 | Eurofeedback Sa | Procede d'epilation |
WO2007058043A1 (ja) * | 2005-11-18 | 2007-05-24 | Beauty Clinical Co., Ltd. | 脱毛装置、脱毛方法 |
US7727516B2 (en) * | 2006-02-28 | 2010-06-01 | The Procter & Gamble Company | Reduction of hair growth |
US20080031833A1 (en) * | 2006-03-13 | 2008-02-07 | Oblong John E | Combined energy and topical composition application for regulating the condition of mammalian skin |
US7586957B2 (en) | 2006-08-02 | 2009-09-08 | Cynosure, Inc | Picosecond laser apparatus and methods for its operation and use |
US8343147B2 (en) | 2006-10-24 | 2013-01-01 | Ec Point Medical, Inc. | Electrolytic tissue treatment |
US20080208179A1 (en) * | 2006-10-26 | 2008-08-28 | Reliant Technologies, Inc. | Methods of increasing skin permeability by treatment with electromagnetic radiation |
US20080154247A1 (en) * | 2006-12-20 | 2008-06-26 | Reliant Technologies, Inc. | Apparatus and method for hair removal and follicle devitalization |
WO2008131302A2 (en) | 2007-04-19 | 2008-10-30 | The Foundry, Inc. | Methods and apparatus for reducing sweat production |
US8688228B2 (en) | 2007-04-19 | 2014-04-01 | Miramar Labs, Inc. | Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy |
EP2837351B1 (en) | 2007-04-19 | 2018-05-30 | Miramar Labs, Inc. | Systems for creating an effect using microwave energy to specified tissue |
EP2767308B1 (en) | 2007-04-19 | 2016-04-13 | Miramar Labs, Inc. | Devices, and systems for non-invasive delivery of microwave therapy |
US20100211059A1 (en) | 2007-04-19 | 2010-08-19 | Deem Mark E | Systems and methods for creating an effect using microwave energy to specified tissue |
EP2164418B1 (en) | 2007-06-27 | 2014-01-08 | The General Hospital Corporation | Apparatus for optical inhibition of photodynamic therapy |
JP5545668B2 (ja) | 2007-12-12 | 2014-07-09 | ミラマー ラブズ, インコーポレイテッド | マイクロ波エネルギーを用いる非侵襲性組織治療のためのシステム、装置方法、および手技 |
US8735054B1 (en) | 2008-01-04 | 2014-05-27 | Lifecell Corporation | Acellular tissue matrix preservation solution |
EP2271276A4 (en) | 2008-04-17 | 2013-01-23 | Miramar Labs Inc | SYSTEMS, APPARATUS, METHODS AND PROCEDURES FOR NON-INVASIVE TREATMENT OF TISSUE USING MICROWAVE ENERGY |
WO2009132355A1 (en) | 2008-04-25 | 2009-10-29 | Tria Beauty, Inc. | Optical sensor and method for identifying the presence of skin and the pigmentation of skin |
US8585618B2 (en) * | 2008-12-22 | 2013-11-19 | Cutera, Inc. | Broad-area irradiation of small near-field targets using ultrasound |
US8469779B1 (en) * | 2009-01-02 | 2013-06-25 | Lifecell Corporation | Method for debristling animal skin |
US9150318B1 (en) | 2009-01-02 | 2015-10-06 | Lifecell Corporation | Method for sterilizing an acellular tissue matrix |
BR112012020673A2 (pt) * | 2010-02-17 | 2016-07-26 | Procter & Gamble | artigo depilatório eficaz |
ES2379703T3 (es) * | 2010-03-26 | 2012-04-30 | The Procter And Gamble Company | Método de depilación y kit para depilación |
WO2011119557A2 (en) * | 2010-03-26 | 2011-09-29 | The Procter & Gamble Company | Kit and method for removing hair |
AU2011312343C1 (en) | 2010-10-05 | 2015-04-02 | Lifecell Corporation | Machine and method for hair or bristle removal |
US9314301B2 (en) | 2011-08-01 | 2016-04-19 | Miramar Labs, Inc. | Applicator and tissue interface module for dermatological device |
KR102136901B1 (ko) | 2012-04-18 | 2020-07-22 | 싸이노슈어, 엘엘씨 | 피코초 레이저 장치 및 그를 사용한 표적 조직의 치료 방법 |
AU2013313105B2 (en) * | 2012-09-10 | 2016-07-07 | Sun Pharmaceutical Industries, Inc. | A method for the permanent removal of hair |
GB201217915D0 (en) * | 2012-10-05 | 2012-11-21 | Trigiante Giuseppe | Composition |
WO2014145707A2 (en) | 2013-03-15 | 2014-09-18 | Cynosure, Inc. | Picosecond optical radiation systems and methods of use |
WO2015013502A2 (en) | 2013-07-24 | 2015-01-29 | Miramar Labs, Inc. | Apparatus and methods for the treatment of tissue using microwave energy |
US20180177700A1 (en) * | 2016-12-28 | 2018-06-28 | Adam M. Rotunda | Hair removal compositions and methods |
EP3759770A4 (en) | 2018-02-26 | 2021-12-08 | Cynosure, LLC | Q-SWITCHED CAVITY DUMP SUBNANO CUSTOMER LASER |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3538919A (en) * | 1967-04-07 | 1970-11-10 | Gregory System Inc | Depilation by means of laser energy |
US3794028A (en) * | 1973-02-27 | 1974-02-26 | A Griffin | Method for injecting chemicals into the papilla for depilation |
US4317450A (en) * | 1979-05-29 | 1982-03-02 | Edward Chalmers | Method of epilation |
US4388926A (en) * | 1980-12-22 | 1983-06-21 | Ethicon, Inc. | High compliance monofilament surgical sutures comprising poly[alkylene terephthalate-co-(2-alkenyl or alkyl)succinate] |
US4388924A (en) * | 1981-05-21 | 1983-06-21 | Weissman Howard R | Method for laser depilation |
GB2123287B (en) * | 1982-07-09 | 1986-03-05 | Anna Gunilla Sutton | Depilaton device |
US4693885A (en) * | 1984-07-18 | 1987-09-15 | Nippon Petrochemicals Co., Ltd. | Tetrapyrrole therapeutic agents |
US4977177A (en) * | 1985-04-30 | 1990-12-11 | Nippon Petrochemicals Company, Ltd. | Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents |
US5079262A (en) * | 1989-07-28 | 1992-01-07 | Queen's University At Kingston | Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid |
US5234940A (en) * | 1989-07-28 | 1993-08-10 | Queen's University | Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof |
US5026369A (en) * | 1990-03-05 | 1991-06-25 | Cole Hubert L | Non-invasive method of removing hair through electrolysis |
US5059192A (en) * | 1990-04-24 | 1991-10-22 | Nardo Zaias | Method of hair depilation |
US5169398A (en) * | 1990-09-21 | 1992-12-08 | Glaros Nicholas G | Electronic hair remover |
US5219878A (en) * | 1990-10-05 | 1993-06-15 | Queen's University | Tetrapyrrole hydroxyalkylamide photochemotherapeutic agents |
US5226907A (en) * | 1991-10-29 | 1993-07-13 | Tankovich Nikolai I | Hair removal device and method |
US5669916A (en) * | 1994-09-28 | 1997-09-23 | The General Hospital Corporation | Method of hair removal |
US6143287A (en) * | 1996-02-27 | 2000-11-07 | New York Blood Center, Inc. | Method and composition for hair removal |
-
1994
- 1994-09-28 US US08/314,082 patent/US5669916A/en not_active Expired - Lifetime
-
1995
- 1995-09-22 CA CA002201123A patent/CA2201123C/en not_active Expired - Fee Related
- 1995-09-22 JP JP8511961A patent/JPH10506554A/ja active Pending
- 1995-09-22 AT AT95934539T patent/ATE273049T1/de not_active IP Right Cessation
- 1995-09-22 ES ES95934539T patent/ES2225848T3/es not_active Expired - Lifetime
- 1995-09-22 WO PCT/US1995/012275 patent/WO1996009853A1/en active IP Right Grant
- 1995-09-22 EP EP95934539A patent/EP0783347B1/en not_active Expired - Lifetime
- 1995-09-22 CN CNB95195847XA patent/CN1179766C/zh not_active Expired - Fee Related
- 1995-09-22 KR KR1019970701995A patent/KR970706038A/ko not_active Application Discontinuation
- 1995-09-22 DE DE69533360T patent/DE69533360T2/de not_active Expired - Lifetime
-
1997
- 1997-07-11 US US08/893,856 patent/US5989267A/en not_active Expired - Lifetime
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113730576A (zh) * | 2021-08-31 | 2021-12-03 | 佛山市第一人民医院(中山大学附属佛山医院) | 一种激光脱毛的纳米光热材料及其制备方法 |
CN114246673A (zh) * | 2021-12-21 | 2022-03-29 | 西安欧益光电科技有限公司 | 一种超声辅助激光高效精准脱毛美容方法及装置 |
Also Published As
Publication number | Publication date |
---|---|
ATE273049T1 (de) | 2004-08-15 |
US5669916A (en) | 1997-09-23 |
KR970706038A (ko) | 1997-11-03 |
EP0783347A4 (en) | 2000-06-07 |
DE69533360T2 (de) | 2005-08-11 |
US5989267A (en) | 1999-11-23 |
CA2201123C (en) | 2008-02-19 |
EP0783347B1 (en) | 2004-08-11 |
AU689962B2 (en) | 1998-04-09 |
DE69533360D1 (de) | 2004-09-16 |
EP0783347A1 (en) | 1997-07-16 |
WO1996009853A1 (en) | 1996-04-04 |
JPH10506554A (ja) | 1998-06-30 |
ES2225848T3 (es) | 2005-03-16 |
CN1179766C (zh) | 2004-12-15 |
AU3685095A (en) | 1996-04-19 |
CA2201123A1 (en) | 1996-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1179766C (zh) | 去除毛发的方法 | |
US6183773B1 (en) | Targeting of sebaceous follicles as a treatment of sebaceous gland disorders | |
CA2422865C (en) | Aminolevulinic acid photodynamic therapy for treating sebaceous gland disorders | |
JP4907057B2 (ja) | 脱毛用発色団の局所的塗布 | |
US8096982B2 (en) | Method and apparatus to enhance optical transparency of biological tissues | |
JPS63249577A (ja) | 永久脱毛法、脱毛用製剤および器材 | |
EP2248536A2 (en) | Topical Aminolevulinic acid-photodynamic therapy for acne vulgaris | |
KR20040075078A (ko) | 젊어보이고, 작은 구멍의 매끄러운 피부를 생성하는 방법및 프로세스 | |
JP2005514142A5 (zh) | ||
CA2884306C (en) | A method for the permanent removal of hair | |
AU689962C (en) | Method of hair removal | |
JP2000080018A (ja) | レーザトリートメント用パック | |
US20100022997A1 (en) | Method and process for producing youthful-appearing, small-pored, and smooth skin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20041215 Termination date: 20110922 |